Healthy Body, Healthy Bones After Bariatric Surgery Trial

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Bariatric Surgery Candidate, Bone Loss, Bone Resorption

In brief

One in three adults in the United States suffers from obesity. Bariatric surgery is an increasingly utilized and effective treatment for obesity and obesity-related comorbidities, however, the massive weight loss associated with bariatric surgery adversely affects bone leads to an increased risk of fracture. Bisphosphonate medications, such as zoledronic acid, are used to treat bone loss in patients with osteoporosis, and this study investigates whether this medication can prevent bone loss associated with surgical weight loss procedures.

Key facts

Study ID
NCT04279392
Run by
University of Nebraska
People needed
10
Starts
2020-09-01
Expected to finish
2022-12-30
Last updated by the study team
2024-09-24

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.